All pairs

Atazanavir–cobicistat and Glecaprevir–pibrentasvir

Desk tier: Avoid together

Mechanism: weak CYP3A4 inhibition of clearance (↑ exposure)

“The concomitant use of EVOTAZ and the following drugs in Table 1, are contraindicated”
Evotaz (atazanavir/cobicistat), section 4 CONTRAINDICATIONS (Table 1). DailyMed label

Open this pair in the desk

All pairs for Atazanavir–cobicistat · Glecaprevir–pibrentasvir

Enzyme behind this pair: CYP3A4

Educational reference only. Not FDA-cleared. The Prescribing Information governs.